33669413|t|Vaccine Development for Herpes Simplex Viruses: A Commentary of Special Issue Editors.
33669413|a|Herpes simplex virus type 1 and 2 (HSV1 and HSV2) are global, widespread human pathogens transmitted by direct contact that cause lifelong, recurrent asymptomatic and painful symptomatic clinical illnesses (cold sores, keratitis, blepharitis, meningitis, encephalitis, genital infections), overt disease and severe sequelae in neonatal and immune-compromised patients, and increased risk of cervical cancer and other sexually transmitted infections, including HIV [...].
33669413	24	46	Herpes Simplex Viruses	Disease	MESH:D006561
33669413	87	120	Herpes simplex virus type 1 and 2	Species	
33669413	122	126	HSV1	Species	10298
33669413	131	135	HSV2	Species	10310
33669413	160	165	human	Species	9606
33669413	294	304	cold sores	Disease	MESH:D006560
33669413	306	315	keratitis	Disease	MESH:D007634
33669413	317	328	blepharitis	Disease	MESH:D001762
33669413	330	340	meningitis	Disease	MESH:D008580
33669413	342	354	encephalitis	Disease	MESH:D004660
33669413	356	374	genital infections	Disease	MESH:D007239
33669413	433	445	-compromised	Disease	
33669413	446	454	patients	Species	9606
33669413	478	493	cervical cancer	Disease	MESH:D002583
33669413	504	535	sexually transmitted infections	Disease	MESH:D012749
33669413	547	550	HIV	Disease	MESH:D015658

